Impact of a pharmacist-led adalimumab biosimilar interchange protocol on order processing time

20260 citationsJournal Article

Authors

Abstract

This study indicates that utilization of a pharmacist-led interchange protocol may improve the order processing time for biosimilars. Focused efforts could prioritize comparison of the rates of discontinuation for adalimumab products.

Topics & Keywords

Publication Details

Published in: American Journal of Health-System Pharmacy

DOI: 10.1093/ajhp/zxag072

Field-Weighted Citation Impact: 0.00

Command Palette

Impact of a pharmacist-led adalimumab biosimilar interchange protocol on order processing time

Authors

Abstract

Topics & Keywords

Publication Details